The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages
Open accessAbstract
The Krebs cycle-derived metabolite itaconate and its derivatives suppress the inflammatory response in pro-inflammatory "M1" macrophages. However, alternatively activated "M2" macrophages can take up itaconate. We therefore examined the effect of itaconate and 4-octyl itaconate (OI) on M2 macrophage activation. We demonstrate that itaconate and OI inhibit M2 polarization and metabolic remodeling. Examination of IL-4 signaling revealed inhibition of JAK1 and STAT6 phosphorylation by both itaconate and OI. JAK1 activation was also inhibited by OI in response to IL-13, interferon-β, and interferon-γ in macrophages and in T helper 2 (Th2) cells. Importantly, JAK1 was directly modified by itaconate derivatives at multiple residues, including cysteines 715, 816, 943, and 1130. Itaconate and OI also inhibited JAK1 kinase activity. Finally, OI treatment suppressed M2 macrophage polarization and JAK1 phosphorylation in vivo. We therefore identify itaconate and OI as JAK1 inhibitors, suggesting a new strategy to inhibit JAK1 in M2 macrophage-driven diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
Italiani, P., & Boraschi, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00514 · Cited by 2,067
Jha, A. K., Huang, S. C.-C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K. M., Ashall, J., Everts, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.005 · Cited by 2,066
The metabolic signature of macrophage responses
Viola, A., Munari, F., Sánchez-Rodríguez, R., Scolaro, T., & Castegna, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01462 · Cited by 2,021
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
Mills, E. L., Ryan, D. G., Prag, H. A., Dikovskaya, D., Menon, D., Zaslona, Z., Jedrychowski, M. P., Costa, A. S. H., Higgins, M., Hams, E., et al. (2018) · Nature · doi:10.1038/nature25986 · Cited by 1,885
Self-citationNrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11624 · Cited by 1,878
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Rőszer, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/816460 · Cited by 1,762
Lampropoulou, V., Sergushichev, A., Bambouskova, M., Nair, S., Vincent, E. E., Loginicheva, E., Cervantes-Barragan, L., Ma, X., Huang, S. C.-C., Griss, T., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.004 · Cited by 1,541
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Schwartz, D. M., Kanno, Y., Villarino, A., Ward, M., Gadina, M., & O'Shea, J. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.201 · Cited by 1,266
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming
Liu, P.-S., Wang, H., Li, X., Chao, T., Teav, T., Christen, S., Di Conza, G., Cheng, W.-C., Chou, C.-H., Vavakova, M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3796 · Cited by 1,264
Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis
Bambouskova, M., Gorvel, L., Lampropoulou, V., Sergushichev, A., Loginicheva, E., Johnson, K., Korenfeld, D., Mathyer, M. E., Kim, H., Huang, L.-H., et al. (2018) · Nature · doi:10.1038/s41586-018-0052-z · Cited by 713
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
Kornberg, M. D., Bhargava, P., Kim, P. M., Putluri, V., Snowman, A. M., Putluri, N., Calabresi, P. A., & Snyder, S. H. (2018) · Science · doi:10.1126/science.aan4665 · Cited by 687
Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes
Junttila, I. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00888 · Cited by 684
Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages
Chávez-Galán, L., Olleros, M. L., Vesin, D., & Garcia, I. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00263 · Cited by 653
The TSC-mTOR pathway regulates macrophage polarization
Byles, V., Covarrubias, A. J., Ben-Sahra, I., Lamming, D. W., Sabatini, D. M., Manning, B. D., & Horng, T. (2013) · Nature Communications · doi:10.1038/ncomms3834 · Cited by 633
Itaconate: the poster child of metabolic reprogramming in macrophage function
O’Neill, L. A. J., & Artyomov, M. N. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0128-5 · Cited by 629
Self-citationThe Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
Hooftman, A., Angiari, S., Hester, S., Corcoran, S. E., Runtsch, M. C., Ling, C., Ruzek, M. C., Slivka, P. F., McGettrick, A. F., Banahan, K., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.016 · Cited by 609
Self-citationControl of Macrophage Activation and Function by PPARs
Chawla, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.216523 · Cited by 531
ProLuCID: An improved SEQUEST-like algorithm with enhanced sensitivity and specificity
Xu, T., Park, S. K., Venable, J. D., Wohlschlegel, J. A., Diedrich, J. K., Cociorva, D., Lu, B., Liao, L., Hewel, J., Han, X., et al. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.07.001 · Cited by 511
Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring
Zhu, K., Borrelli, K. W., Greenwood, J. R., Day, T., Abel, R., Farid, R. S., & Harder, E. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500118s · Cited by 462
Olagnier, D., Farahani, E., Thyrsted, J., Blay-Cadanet, J., Herengt, A., Idorn, M., Hait, A., Hernaez, B., Knudsen, A., Iversen, M. B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18764-3 · Cited by 455
4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects
Liao, S.-T., Han, C., Xu, D.-Q., Fu, X.-W., Wang, J.-S., & Kong, L.-Y. (2019) · Nature Communications · doi:10.1038/s41467-019-13078-5 · Cited by 451
Szanto, A., Balint, B. L., Nagy, Z. S., Barta, E., Dezso, B., Pap, A., Szeles, L., Poliska, S., Oros, M., Evans, R. M., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.009 · Cited by 448
Role for NLRP3 Inflammasome–mediated, IL-1β–Dependent Responses in Severe, Steroid-Resistant Asthma
Kim, R. Y., Pinkerton, J. W., Essilfie, A. T., Robertson, A. A. B., Baines, K. J., Brown, A. C., Mayall, J. R., Ali, M. K., Starkey, M. R., Hansbro, N. G., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1830oc · Cited by 435
Self-citationChi, H., Liu, C., Yang, H., Zeng, W.-F., Wu, L., Zhou, W.-J., Wang, R.-M., Niu, X.-N., Ding, Y.-H., Zhang, Y., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4236 · Cited by 434
Self-citationGlycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation
Wang, F., Zhang, S., Vuckovic, I., Jeon, R., Lerman, A., Folmes, C. D., Dzeja, P. P., & Herrmann, J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.012 · Cited by 415
Coupling Krebs cycle metabolites to signalling in immunity and cancer
Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0014-7 · Cited by 398
Self-citationIL-4/IL-13 signaling beyond JAK/STAT
Jiang, H., Harris, M. B., & Rothman, P. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107604 · Cited by 396
Finkelman, F. D., Madden, K. B., Morris, S. C., Holmes, J. M., Boiani, N., Katona, I. M., & Maliszewski, C. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1235 · Cited by 366
S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate
Qin, W., Qin, K., Zhang, Y., Jia, W., Chen, Y., Cheng, B., Peng, L., Chen, N., Liu, Y., Zhou, W., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0323-5 · Cited by 313
Self-citationWillenborg, S., Sanin, D. E., Jais, A., Ding, X., Ulas, T., Nüchel, J., Popović, M., MacVicar, T., Langer, T., Schultze, J. L., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.10.004 · Cited by 310
Kuljanin, M., Mitchell, D. C., Schweppe, D. K., Gikandi, A. S., Nusinow, D. P., Bulloch, N. J., Vinogradova, E. V., Wilson, D. L., Kool, E. T., Mancias, J. D., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00778-3 · Cited by 305
Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
Weiss, J. M., Davies, L. C., Karwan, M., Ileva, L., Ozaki, M. K., Cheng, R. Y. S., Ridnour, L. A., Annunziata, C. M., Wink, D. A., & McVicar, D. W. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99169 · Cited by 267
Lupardus, P. J., Ultsch, M., Wallweber, H., Bir Kohli, P., Johnson, A. R., & Eigenbrot, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401180111 · Cited by 229
The Immunomodulatory Potential of the Metabolite Itaconate
Hooftman, A., & O’Neill, L. A. J. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.05.007 · Cited by 228
Self-citationKim, R. Y., Horvat, J. C., Pinkerton, J. W., Starkey, M. R., Essilfie, A. T., Mayall, J. R., Nair, P. M., Hansbro, N. G., Jones, B., Haw, T. J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.038 · Cited by 210
Self-citationFaas, M., Ipseiz, N., Ackermann, J., Culemann, S., Grüneboom, A., Schröder, F., Rothe, T., Scholtysek, C., Eberhardt, M., Böttcher, M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.09.010 · Cited by 205
Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells
Blewett, M. M., Xie, J., Zaro, B. W., Backus, K. M., Altman, A., Teijaro, J. R., & Cravatt, B. F. (2016) · Science Signaling · doi:10.1126/scisignal.aaf7694 · Cited by 194
Metabolism Supports Macrophage Activation
Langston, P. K., Shibata, M., & Horng, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00061 · Cited by 185
Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury
Cordes, T., Lucas, A., Divakaruni, A. S., Murphy, A. N., Cabrales, P., & Metallo, C. M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.019 · Cited by 162
Itaconate controls the severity of pulmonary fibrosis
Ogger, P. P., Albers, G. J., Hewitt, R. J., O’Sullivan, B., Powell, J. E., Calamita, E., Ghai, P., Walker, S. A., McErlean, P. K., Saunders, P., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc1884 · Cited by 161
Ganta, V. C., Choi, M., Kutateladze, A. A., Fox, T. E., Farber, C. R., & Annex, B. H. (2017) · Circulation · doi:10.1161/circulationaha.116.025490 · Cited by 159
PPARγ is a nexus controlling alternative activation of macrophages via glutamine metabolism
Nelson, V. L., Nguyen, H. C. B., García‐Cañaveras, J. C., Briggs, E. R., Ho, W. Y., DiSpirito, J. R., Marinis, J. M., Hill, D. A., & Lazar, M. A. (2018) · Genes & Development · doi:10.1101/gad.312355.118 · Cited by 154
Chemoproteomic Profiling of Itaconation by Bioorthogonal Probes in Inflammatory Macrophages
Qin, W., Zhang, Y., Tang, H., Liu, D., Chen, Y., Liu, Y., & Wang, C. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b11962 · Cited by 153
Self-citationEssilfie, A., Horvat, J. C., Kim, R., Mayall, J., Pinkerton, J., Beckett, E., Starkey, M. R., Simpson, J. L., Foster, P. S., Gibson, P. G., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206067 · Cited by 138
Self-citationNeonatal Chlamydial Infection Induces Mixed T-Cell Responses That Drive Allergic Airway Disease
Horvat, J. C., Beagley, K. W., Wade, M. A., Preston, J. A., Hansbro, N. G., Hickey, D. K., Kaiko, G. E., Gibson, P. G., Foster, P. S., & Hansbro, P. M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-1005oc · Cited by 132
Self-citationCellular mechanisms underlying steroid-resistant asthma
Wadhwa, R., Dua, K., Adcock, I. M., Horvat, J. C., Kim, R., & Hansbro, P. M. (2019) · European Respiratory Review · doi:10.1183/16000617.0096-2019 · Cited by 118
Self-citationKuo, P., Weng, W., Scofield, B. A., Paraiso, H. C., Brown, D. A., Wang, P., Yu, I.-C. I., & Yen, J.-H. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01768-7 · Cited by 116
Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases
Toms, A. V., Deshpande, A. J., McNally, R., Jeong, Y., Rogers, J. M., Kim, C. U., Gruner, S. M., Ficarro, S. B., Marto, J. A., Sattler, M., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2673 · Cited by 114
Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol
Goedken, E. R., Argiriadi, M. A., Banach, D. L., Fiamengo, B. A., Foley, S. E., Frank, K. E., George, J. S., Harris, C. M., Hobson, A. D., Ihle, D. C., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.595181 · Cited by 101
Self-citationItaconate: A Metabolite Regulates Inflammation Response and Oxidative Stress
Li, R., Zhang, P., Wang, Y., & Tao, K. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5404780 · Cited by 93
Jaiswal, A. K., Yadav, J., Makhija, S., Mazumder, S., Mitra, A., Suryawanshi, A. S., Sandey, M., & Mishra, A. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00462-y · Cited by 88
Puchalska, P., Huang, X., Martin, S. E., Han, X., Patti, G. J., & Crawford, P. A. (2018) · iScience · doi:10.1016/j.isci.2018.10.029 · Cited by 79
Ashino, S., Takeda, K., Li, H., Taylor, V., Joetham, A., Pine, P. R., & Gelfand, E. W. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.036 · Cited by 72
Chemoproteomic profiling of itaconations in Salmonella
Zhang, Y., Qin, W., Liu, D., Liu, Y., & Wang, C. (2021) · Chemical Science · doi:10.1039/d1sc00660f · Cited by 47
Self-citationMonocyte Differentiation towards Protumor Activity Does Not Correlate with M1 or M2 Phenotypes
Chimal-Ramírez, G. K., Espinoza‐Sánchez, N. A., Chávez-Sanchéz, L., Arriaga‐Pizano, L., & Fuentes‐Pananá, E. M. (2016) · Journal of Immunology Research · doi:10.1155/2016/6031486 · Cited by 45
Identification of a redox-sensitive switch within the JAK2 catalytic domain
Smith, J. K., Patil, C. N., Patlolla, S. S., Gunter, B. W., Booz, G. W., & Duhé, R. J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.12.025 · Cited by 43
Recent advances in JAK3 inhibition: Isoform selectivity by covalent cysteine targeting
Förster, M., Gehringer, M., & Laufer, S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.07.079 · Cited by 43
Siu, T., Brubaker, J. D., Fuller, P. H., Torres, L., Zeng, H., Close, J., Mampreian, D. M., Shi, F., Liu, D., Fradera, X., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01135 · Cited by 21
Therapeutic potential of tricarboxylic acid cycle metabolite itaconate in cardiovascular diseases
Yang, C., Liu, T., & Shi, G. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102938 · Cited by 18
Cited by
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue, C., Yao, Q., Gu, X., Shi, Q., Yuan, X., Chu, Q., Bao, Z., Lu, J., & Li, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01468-7 · Cited by 699
Metabolism, metabolites, and macrophages in cancer
Li, M., Yang, Y., Xiong, L., Jiang, P., Wang, J., & Li, C. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01478-6 · Cited by 507
Macrophage Polarization and Reprogramming in Acute Inflammation: A Redox Perspective
Pérez, S., & Rius-Pérez, S. (2022) · Antioxidants · doi:10.3390/antiox11071394 · Cited by 312
4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING
Li, W., Li, Y., Kang, J., Jiang, H., Gong, W., Chen, L., Wu, C., Liu, M., Wu, X., Zhao, Y., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112145 · Cited by 117
Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses
Lesbats, J., Brillac, A., Reisz, J. A., Mukherjee, P., Lhuissier, C., Fernández-Monreal, M., Dupuy, J.-W., Sequeira, A., Tioli, G., De La Calle Arregui, C., et al. (2025) · Nature · doi:10.1038/s41586-025-08629-4 · Cited by 74
Metadata
- Authors
- Runtsch, M. C., Angiari, S., Hooftman, A., Wadhwa, R., Zhang, Y., Zheng, Y., Spina, J. S., Ruzek, M. C., Argiriadi, M. A., McGettrick, A. F., Mendez, R. S., Zotta, A., Peace, C. G., Walsh, A., Chirillo, R., Hams, E., Fallon, P. G., Jayaraman, R., Dua, K., Brown, A. C., Kim, R. Y., Horvat, J. C., Hansbro, P. M., Wang, C., & O’Neill, L. A. J.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 34
- Issue
- 3
- Pages
- 487-501.e8
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W4214769648
- Cited by
- 323
- References
- 62
- FWCI
- 20.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.